ENDONOVO THERAPEUTICS, INC. Increase (Decrease) in Derivative Liabilities
ENDONOVO THERAPEUTICS, INC. (ENDV) reported Increase (Decrease) in Derivative Liabilities of -$2.65 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2016-11-14
- ENDONOVO THERAPEUTICS, INC. increase (decrease) in derivative liabilities for the quarter ending 2016-09-30 was -$47.00K.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month |
|---|---|---|---|
| 2016-09-30 | -$47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$2.65M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$2.60M 10-Q · filed 2016-08-12 |